IART logo

INTEGRA LIFESCIENCES HOLDING

IARTNASDAQ
๐Ÿ† #2298 by market capEarnings Oct 28US Equity
$16.64โ–ฒ $0.38 (+2.27%)
๐ŸŒ™ After hours$16.94โ–ฒ 1.82%Regular close ยท extended-hours price shown
๐Ÿ””
Track IART
Get earnings, price moves & breaking news on Telegram
Track
24hโ–ฒ 2.3%
7dโ–ฒ 7.1%
14dโ–ฒ 3.5%
30dโ–ผ 1.5%
ytdโ–ฒ 34.1%
1yโ–ฒ 16.0%
๐ŸฆMarket Cap
$1.29B
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
+1.5%
Slowing
๐Ÿ“ŠGross Margin
53.7%
Healthy
๐Ÿ’ตFCF Margin
2.4%
Thin
โš–๏ธP/S Ratio
0.8x
Cheap
Otter Score
88
Very Good

Trading Snapshot

Day Range
$16.45 โ€“ $16.85
52-Week Range
$8.70 โ€“ $20.49
Volume
$2.02B
Avg Volume
$2.25B
Shares Outstanding
77.8M
Next Earnings
Oct 23, 2026

Fundamentals Snapshot

Annual Revenue
$1.64B
Last Q Revenue
$419M
P/E Ratio
-180.5
P/S Ratio
0.8x
EPS (TTM)
$-0.09
Dividend Yield
0.00%
Dilution (1yr)
โˆ’0.3%

Why Investors Own IART

  • โœ“High-growth profile โ€” revenue up +31.8% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 79% gross margin and 23% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

IART logo

INTEGRA LIFESCIENCES HOLDING

IART
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$1.6Bโ–ฒ +1.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
51.7%โ–ผ โˆ’5.6% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnโ€™t profitable yet.
$68Mโ–ฒ +140.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
โˆ’$45Mโ–ผ โˆ’281.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing ownerโ€™s slice.
76.8Mโ–ผ โˆ’0.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
โˆ’$1.8Bโ–ผ โˆ’$60M YoY
StockOtter ยท stockotter.space

About INTEGRA LIFESCIENCES HOLDING

Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.

๐Ÿฆฆ

Otter Score Breakdown

How it's scoredFive components, each rated 1โ€“5โ˜… and equally weighted (20%), averaged to a 0โ€“100 score:๐Ÿ’Ž Quality โ€” gross margin๐Ÿš€ Growth โ€” revenue YoYโš–๏ธ Valuation โ€” P/S ratioโšก Momentum โ€” 30-day price change๐Ÿ’ง Dilution โ€” 1-yr share issuance (buybacks score higher)
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿ’งDilutionโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Very Good
88/100

Analyst Price Target

โ“˜
Average Target
$21.98
โ–ฒ +32.1% Upside
High Target$23.83
Low Target$16.91
Based on 23 analysts

Latest News & Updates

๐Ÿš€
Zacks Investment Researchยท13h ago

IART or PEN: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical - Instruments sector have probably already heard of Integra LifeSciences (IART) and Penumbra (PEN). But which of these two companies is the best option for those looking fo

GlobeNewsWireยท17h ago

Integra LifeSciences Announces 100th Patient Enrolled in AERAยฎ Pediatric Registry

Prospective, multicenter registry advances toward planned enrollment of 300 pediatric patients Prospective, multicenter registry advances toward planned enrollment of 300 pediatric patients

GlobeNewsWireยท4d ago

Integra LifeSciences Marks 20 Years of CUSAยฎ Technology with Liver Surgery Education at ACS Clinical Congress 2026

Company to feature surgeon-led educational programming and technologies supporting liver surgery Company to feature surgeon-led educational programming and technologies supporting liver surgery

Zacks Investment Researchยท12d ago

Here's Why Integra LifeSciences (IART) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Seeking Alphaยท14d ago

Integra LifeSciences Holdings Corporation (IART) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Integra LifeSciences Holdings Corporation (IART) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

GlobeNewsWireยท25d ago

Integra LifeSciences to Present at the 2026 Wells Fargo Healthcare Conference and the 2026 Morgan Stanley Healthcare Conference

PRINCETON, N.J., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Lea Knight, chief financial officer, and Mic